Clinical Trials Directory

Trials / Completed

CompletedNCT03062969

The Transition From Blastomere to Trophectoderm Biopsy: Comparing Two PGS Strategies

Status
Completed
Phase
Study type
Observational
Enrollment
383 (actual)
Sponsor
Fundacion Dexeus · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Shortly after the implementation of Comprehensive Chromosome Screening (CCS) techniques for Preimplantation Genetic Screening (PGS) came the transition in biopsy timing. Trophectoderm biopsy is meant to overcome the limitations of cleavage stage biopsy and single cell analysis.

Detailed description

The investigators have recently introduced this new approach and a frozen-thawed policy of euploid blastocysts is routinely performed. This is a single centre retrospective study in patients undergoing a PGS cycle. The aim of the study is to assess the results obtained in a PGS programme after the implementation of a new biopsy timing and transfer policy. Results obtained in PGS cycles with blastocyst biopsy and frozen-thawed embryo transfer were analysed in comparison to cycles with cleavage stage biopsy and fresh blastocyst transfer.

Conditions

Interventions

TypeNameDescription
PROCEDURECleavage stage biopsy group* intracytoplasmatic sperm injection (ICSI)- (Invitro Fertilization)IVF * Time lapse embryo culture * Cleavage stage biopsy * aCGH analysis * Fresh euploid embryo transfer
PROCEDURETrophectoderm biopsy group* ICSI-IVF * Time lapse embryo culture * Day 3 zona pellucida opening * Trophectoderm biopsy * aCGH analysis * Frozen-thawed euploid embryo transfer

Timeline

Start date
2014-01-01
Primary completion
2016-02-28
Completion
2017-01-01
First posted
2017-02-24
Last updated
2017-02-24

Source: ClinicalTrials.gov record NCT03062969. Inclusion in this directory is not an endorsement.